Raymond James & Associates’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.01M Buy
21,180
+467
+2% +$40.8K ﹤0.01% 2220
2024
Q2
$1.73M Sell
20,713
-19,363
-48% -$1.61M ﹤0.01% 2248
2024
Q1
$3.44M Buy
40,076
+8,002
+25% +$651K ﹤0.01% 1822
2023
Q4
$2.65M Buy
32,074
+519
+2% +$38.1K ﹤0.01% 1925
2023
Q3
$2.27M Buy
31,555
+157
+0.5% +$11.9K ﹤0.01% 1951
2023
Q2
$2.38M Buy
31,398
+15,515
+98% +$1.04M ﹤0.01% 1949
2023
Q1
$1M Buy
15,883
+2,061
+15% +$121K ﹤0.01% 2443
2022
Q4
$751K Buy
13,822
+965
+8% +$57.3K ﹤0.01% 2602
2022
Q3
$735K Sell
12,857
-935
-7% -$51.8K ﹤0.01% 2584
2022
Q2
$640K Buy
13,792
+1,154
+9% +$60.5K ﹤0.01% 2751
2022
Q1
$724K Buy
12,638
+78
+0.6% +$4.02K ﹤0.01% 2825
2021
Q4
$662K Sell
12,560
-1,280
-9% -$68.4K ﹤0.01% 2893
2021
Q3
$695K Sell
13,840
-1,152
-8% -$59.7K ﹤0.01% 2823
2021
Q2
$881K Sell
14,992
-37,998
-72% -$2.35M ﹤0.01% 2683
2021
Q1
$3.45M Buy
52,990
+4,529
+9% +$278K ﹤0.01% 1670
2020
Q4
$2.66M Sell
48,461
-12,053
-20% -$615K ﹤0.01% 1720
2020
Q3
$2.67M Sell
60,514
-78,400
-56% -$3.45M ﹤0.01% 1579
2020
Q2
$5.86M Sell
138,914
-26,906
-16% -$1.04M 0.01% 1093
2020
Q1
$6.59M Sell
165,820
-22,776
-12% -$963K 0.01% 918
2019
Q4
$8.4M Buy
188,596
+41,861
+29% +$1.61M 0.01% 975
2019
Q3
$5.02M Buy
146,735
+57,486
+64% +$1.99M 0.01% 1223
2019
Q2
$3.36M Buy
89,249
+27,797
+45% +$951K ﹤0.01% 1476
2019
Q1
$1.88M Sell
61,452
-15,265
-20% -$466K ﹤0.01% 1805
2018
Q4
$2.12M Buy
+76,717
New +$2.11M ﹤0.01% 1620

Other funds holding ACA

Raymond James & Associates's ACA Position: Q3 2024 in Review

Raymond James & Associates increased its Arcosa (ACA) stake by 2.3% in Q3 2024, buying an estimated $40.8K and bringing the position to 21,180 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2220.

Raymond James & Associates first reported a position in ACA in Q4 2018 and has held it in 24 quarters since. The position peaked at $8.4M in Q4 2019. 324 funds tracked by Wall St. Rank hold ACA as of Q3 2024.

  • Raymond James & Associates held 21,180 shares of Arcosa worth $2.01M as of Q3 2024.
  • Raymond James & Associates bought 467 Arcosa shares in Q3 2024, an estimated $40.8K.
  • Arcosa made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2220 holding.
  • Raymond James & Associates first reported a position in Arcosa in Q4 2018 and has held it in 24 quarters since.
  • Raymond James & Associates's Arcosa position peaked at $8.4M in Q4 2019.
  • 324 funds tracked by Wall St. Rank held Arcosa as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.